Constipation in early de novo Parkinson’s disease: Prevalence and correlates with clinical features, imaging and non-imaging biomarkers
Objective: To explore the association between constipation and clinical features, imaging and non-imaging biomarkers in early de novo (untreated) Parkinson's disease (PD) patients. Background: Constipation…Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)
Objective: A new FEES protocol specified for dysphagia diagnosis among Parkinson's disease (PD) patients was recently developed in a prior two-phased study¹, which is now…Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?
Objective: To compare blood pressure (BP) changes in nighttime by continuous twenty four hour blood pressure monitoring (RR) as a postulated tool to describe sleep…Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study
Objective: To investigate the association of GBA variants with pre-diagnostic features of Parkinson's disease (PD) within the PREDICT-PD cohort. Background: Subtle motor and non-motor symptoms…α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients
Objective: To explore the association between levels of α-synuclein burden and urinary dysfunction in early de novo (untreated) Parkinson's disease (PD) patients. Background: Urinary dysfunction…The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale
Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…The prevalence of gastrointestinal disorders and non-motor symptoms in a cohort of patients with Parkinson’s disease
Objective: The aim of this investigation was to estimate the prevalence of gastrointestinal disorders (GID) and non-motor symptoms (NMS) in a cohort of a cohort…Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers
Objective: 1) To identify patient barriers to help-seeking for non-motor symptoms (NMS) from their Parkinson's healthcare provider, 2) To determine whether barriers are symptom specific…Non-motor symptoms profiles in UK white Caucasian and Asian as well as overseas Thai and East Indian patients with Parkinson’s disease
Objective: To compare motor and non-motor symptoms (NMS) in white Caucasian (WC) and Asian patients with Parkinson's disease (PwP) living in the UK as well…Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study
Objective: The aim of this study was to systematically investigate the prevalence of psychiatric disorders and factors influencing health-related quality of life (HR-QoL) in cervical…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 63
- Next Page »